OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design and Synthesis of Novel HIV-1 NNRTIs with Bicyclic Cores and with Improved Physicochemical Properties
Ladislav Prener, Ondřej Baszczyňski, Martin Kaiser, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1761-1777
Open Access | Times Cited: 12
Ladislav Prener, Ondřej Baszczyňski, Martin Kaiser, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1761-1777
Open Access | Times Cited: 12
Showing 12 citing articles:
Deciphering the enigmas of non‐nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistance
Kun Zhang, Yujie Zhang, Min Li, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 5
Kun Zhang, Yujie Zhang, Min Li, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 5
Structure-based discovery of novel diarylpyrimidines as potent and selective Non-Nucleoside reverse transcriptase inhibitors: From CH(CN)-Biphenyl-Diarylpyrimidines to C NNH2-Biphenyl-Diarylpyrimidines
Xiaomei Chen, Christophe Pannecouque, Erik De Clercq, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117271-117271
Closed Access
Xiaomei Chen, Christophe Pannecouque, Erik De Clercq, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117271-117271
Closed Access
Recent developments of pyrimidine appended HIV-1 non-nucleoside reverse transcriptase inhibitors
S. Maheen Abdul Rahman, Gurpreet Singh, Md. Sakirul Islam Khan, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108273-108273
Closed Access
S. Maheen Abdul Rahman, Gurpreet Singh, Md. Sakirul Islam Khan, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108273-108273
Closed Access
Identification of a novel small-molecule inhibitor of the HIV-1 reverse transcriptase activity with a non-nucleoside mode of action
Kyung-Lee Yu, YoungHyun Shin, Dong‐Eun Kim, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Kyung-Lee Yu, YoungHyun Shin, Dong‐Eun Kim, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Fragment Hopping-Based Design of Novel Biphenyl-DAPY Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Improved Anti-Resistance Efficacy
Ya-Li Sang, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4755-4767
Closed Access | Times Cited: 10
Ya-Li Sang, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4755-4767
Closed Access | Times Cited: 10
Innovative medicinal chemistry strategies for enhancing drug solubility
Zhangxu He, Weiguang Yang, Feifei Yang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116842-116842
Closed Access | Times Cited: 1
Zhangxu He, Weiguang Yang, Feifei Yang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116842-116842
Closed Access | Times Cited: 1
Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors (2019-2023)
M. Nie, Shuang‐Shuang Zhang, Shuang‐Xi Gu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116973-116973
Closed Access | Times Cited: 1
M. Nie, Shuang‐Shuang Zhang, Shuang‐Xi Gu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116973-116973
Closed Access | Times Cited: 1
Recent Advances in the Synthesis and Applications of m-Aryloxy Phenols
Dinara Amankulova, Gulzat Berganayeva, Bates Kudaibergenova, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2657-2657
Open Access | Times Cited: 2
Dinara Amankulova, Gulzat Berganayeva, Bates Kudaibergenova, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2657-2657
Open Access | Times Cited: 2
Development of novel HEPT analogs featuring significantly improved anti-resistance potency against HIV-1 through chemical space exploration of the tolerant region I
Ruo-Lan Zhou, Christophe Pannecouque, Erik De Clercq, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106783-106783
Closed Access | Times Cited: 2
Ruo-Lan Zhou, Christophe Pannecouque, Erik De Clercq, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106783-106783
Closed Access | Times Cited: 2
New Insights into Strategies for Solubility Improvement
Zhangxu He, Weiguang Yang, Fei Yang, et al.
(2024)
Closed Access
Zhangxu He, Weiguang Yang, Fei Yang, et al.
(2024)
Closed Access
Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention
Juan Carlos Aldave Becerra, Lauren Hitchcock, Khoa Vu, et al.
Microbial Cell (2024) Vol. 11, pp. 207-220
Open Access
Juan Carlos Aldave Becerra, Lauren Hitchcock, Khoa Vu, et al.
Microbial Cell (2024) Vol. 11, pp. 207-220
Open Access
Six-membered ring systems: Diazines and benzo derivatives
K. Alison Rinderspacher
Progress in heterocyclic chemistry (2024), pp. 355-393
Closed Access
K. Alison Rinderspacher
Progress in heterocyclic chemistry (2024), pp. 355-393
Closed Access
